McKesson Corporation is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
McKesson Corp. is a pharmaceutical distributor. It delivers medicines, vaccines, medical supplies, and health information technology. During the pandemic, McKesson delivered millions of doses of the COVID-19 vaccine across the United States, which helped to protect people from the virus. In addition to deliveries, its business solutions help health providers run more efficiently.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Healthcare is a central component of our measure of Humankind Value, as a large contribution to modern life expectancies has come from the last 150 years of medical innovation. McKesson Corp. is responsible for positive Humankind Value. Considerable positive value is associated with Healthcare R&D ($27.8 B), Economic Value ($25.3 B), and Pharmaceuticals ($15.2 B). Positive value from Healthcare R&D and Pharmaceuticals includes the impact of an estimated 891,719.1 additional years lived by people worldwide. Its economic value comes from offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. The Humankind Value of this company can improve with reductions in Opioid Abuse (-$4.0 B) and Workplace Injuries (-$1.0 B). Economic Value, Opioid Abuse, and Workplace Injuries are attached to this company as a result of its direct business activities. Healthcare R&D and Pharmaceuticals are mostly or entirely a result of supply-chain relationships. For this firm, supply chain partners increase an already positive Humankind Value.